Freeline Therapeutics Will Present New Clinical Data From Its Ongoing Phase 1/2 GALILEO-1 Trial Of FLT201 Gene Therapy Candidate, For Gaucher Disease Type 1 At The European Society Of Gene & Cell Therapy Annual Congress
Author: Benzinga Newsdesk | October 16, 2023 07:18am